NeuroTech Insight: Progress in Treatments for ALS and Other Motor Neuron Diseases

The most recent issue of the neurotechnology industry newsletter Neurotech Insights [subscription required] includes a wide-scale industry update on drug development efforts for ALS and other motor neurons diseases. Over a dozen companies are highlighted in the article, including the efforts of Neurimmune, Isis, and NeuralStem.

Click here to read more.

Share this: